Grapefruit USA, Inc: insider trades · United States · SEC (Form 4)

About Grapefruit USA, Inc

Grapefruit USA, Inc. (ticker: GPFT) is a U.S.-based micro-cap company with its securities quoted on the OTC market rather than on a major national exchange such as NYSE or NASDAQ. The company is domiciled in the United States and has its principal executive office in Los Angeles, California. Grapefruit’s corporate history is relatively recent in its current form: it was formerly Imaging3, Inc., and the name change to Grapefruit USA, Inc. was completed in 2020 following a reverse-acquisition style restructuring. For investors, the company should be viewed as a small, highly regulated cannabis-adjacent operating platform rather than a diversified consumer or healthcare platform. Operationally, Grapefruit USA has focused on California’s regulated cannabis ecosystem, with an emphasis on licensed distribution, manufacturing, extraction, packaging, and proprietary product development. Public filings describe product lines including CBD gummies, vaporization cartridges, oils, and topical creams, particularly the Hourglass branded topical line. The company has also described a long-term ambition to develop a larger vertically integrated facility in the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California, intended to combine cultivation, distribution, and laboratory functions. That geographic footprint is primarily concentrated in California, although the legal structure is Delaware-based and the business model depends on U.S. state-level cannabis regulation. From a competitive standpoint, GPFT operates in a crowded market with intense pricing pressure, strict licensing requirements, and materially stronger competitors in terms of scale, capital access, and retail distribution reach. Its strategic logic lies in using regulated distribution as a route to market, while trying to build proprietary formulations and branded products that can support higher margins than pure trading or wholesale activity. However, the company’s small scale, capital constraints, and execution risk mean that it remains far below the market position of established multi-state operators and better-funded branded competitors. Recent filings indicate that Grapefruit USA remained active and was not a shell company as of year-end 2025, with its principal office at 10850 Wilshire Blvd., Ste. 710, Los Angeles, CA 90024. The company reported 1,161,935,082 common shares outstanding at December 31, 2025. For market participants, insider transactions filed on SEC Form 4 are an important monitoring point because GPFT is a thinly traded micro-cap where governance, financing activity, and operational milestones can have an outsized impact on sentiment.